Martin Duddy
Overview
Explore the profile of Martin Duddy including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
39
Citations
1706
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Evangelou N, Garjani A, dasNair R, Hunter R, Tuite-Dalton K, Craig E, et al.
J Neurol Neurosurg Psychiatry
. 2020 Aug;
PMID: 32855290
No abstract available.
12.
Thomas W, Karkhanis S, Hopkins J, Duddy M
Vasc Endovascular Surg
. 2020 Apr;
54(5):389-394.
PMID: 32281501
Background And Aims: The management of persistent type II endoleaks (T2E) is often problematic for the endovascular specialist, with a lack of clear evidence for the best approach for embolization....
13.
Premaratne S, Hopkins J, Duddy M, Tai K, Kay M, Rogoveanu R, et al.
Vasc Endovascular Surg
. 2019 Oct;
54(1):51-57.
PMID: 31601161
Background: Abdominal aortic aneurysm (AAA) repair in patients with organ transplant remains a challenge. We looked at AAA repair in patients with organ transplants at our tertiary liver and kidney...
14.
Palace J, Duddy M, Lawton M, Bregenzer T, Zhu F, Boggild M, et al.
J Neurol Neurosurg Psychiatry
. 2018 Sep;
90(3):251-260.
PMID: 30242090
Background: Because multiple sclerosis (MS) is a chronic disease causing disability over decades, it is crucial to know if the short-term effects of disease-modifying therapies reported in randomised controlled trials...
15.
Lowes H, Pyle A, Duddy M, Hudson G
Mitochondrion
. 2018 Aug;
46:307-312.
PMID: 30098422
Recent studies have linked cell-free mitochondrial DNA (ccf-mtDNA) to neurodegeneration in both Alzheimer's and Parkinson's disease, raising the possibility that the same phenomenon could be seen in other diseases which...
16.
Saviour M, Hamid S, Moore P, Mutch K, Bhojak M, Duddy M, et al.
Neurol Clin Pract
. 2018 Mar;
8(1):74-76.
PMID: 29517081
No abstract available.
17.
Cragg J, Lowry D, Hopkins J, Parker D, Kay M, Duddy M, et al.
Vasc Endovascular Surg
. 2017 Dec;
52(2):93-97.
PMID: 29237359
Purpose: Previous reports have suggested higher periprocedural complications after ipsilateral antegrade femoral arterial access (AA). We looked at a contemporary series comparing complication rates between AA and contralateral retrograde femoral...
18.
Hamid S, Whittam D, Saviour M, Alorainy A, Mutch K, Linaker S, et al.
JAMA Neurol
. 2017 Nov;
75(1):65-71.
PMID: 29131884
Importance: Antibodies to myelin oligodendrocyte glycoprotein IgG (MOG-IgG) are increasingly detected in patients with non-multiple sclerosis-related demyelination, some of whom manifest a neuromyelitis optica (NMO) phenotype. Cortical involvement, encephalopathy, and...
19.
MacDiarmid M, Nepogodiev D, Tiwari A, Duddy M, Carey M, Jobanputra P
Clin Case Rep
. 2017 Jun;
5(6):769-773.
PMID: 28588807
Temporal artery aneurysm is a rare cause of temporal artery swelling in the absence of preceding trauma. Vasculitis other than giant cell arteritis, such as eosinophilic granulomatosis with polyangiitis, should...
20.
Willis M, Pearson O, Illes Z, Sejbaek T, Nielsen C, Duddy M, et al.
Neurol Neuroimmunol Neuroinflamm
. 2017 Jan;
4(2):e320.
PMID: 28101520
Objective: To describe a series of patients with relapsing multiple sclerosis (MS) who experienced significant and unexpected disease activity within the first 12 months after switching from fingolimod to alemtuzumab....